Clinical Trial Update: DX-8951f in Treating Women Who Have Advanced or Recurrent Cancer of the Cervix [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2 study of DX-8951f in women with advanced or recurrent cervical cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• DX-8951f

Snippet

Sponsor: Daiichi Sankyo | Conditions: Cervical Cancer | Phase 2 | Status: COMPLETED